Definitive Contract HHSD200201688480C

This is a $3,620,000.00 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Novartis Vaccines and Diagnostics, Inc. for the "2016 ADULT FLU" program. The contract has a firm fixed price pricing type and an ultimate completion date of February 28, 2017. It is not a set-aside contract. This contract may be related to the CDC's efforts to provide vaccines and diagnostics for influenza preparedness and response, but additional details about the specific products or services being delivered are not provided.